Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2863-2867, May 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werner-Felmayer, G.
Right arrow Articles by Wachter, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Werner-Felmayer, G.
Right arrow Articles by Wachter, H.

Neopterin Formation and Tryptophan Degradation by a Human Myelomonocytic Cell Line (THP-1) upon Cytokine Treatment1

Gabriele Werner-Felmayer, Ernst Robert Werner, Dietmar Fuchs, Arno Hausen, Gilbert Reibnegger and Helmut Wachter2

Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Fritz-Pregl-Str. 3, A-6020 Innsbruck, Austria

Determination of neopterin [D-erythro-6-(1',2',3'-trihydroxypropyl)pterin] in body fluids is a powerful diagnostic tool in a variety of diseases in which activation of cellular immune mechanisms is involved, such as certain malignancies, allograft rejection, and autoimmune and infectious diseases. In vitro, neopterin is released into the supernatant by peripheral blood-derived monocytes/macrophages upon stimulation with {gamma}-interferon. In parallel, cleavage of tryptophan by indoleamine 2,3-dioxygenase is induced. We report here that the human myelomonocytic cell line THP-1 forms neopterin and degrades tryptophan upon treatment with {gamma}-interferon. Like in macrophages {alpha}-interferon and ß-interferon induce these pathways only to a much smaller degree. The action of interferons is enhanced by cotreatment with tumor necrosis factor {alpha}, lipopolysaccharide, or dexamethasone. {gamma}-Interferon-induced neopterin formation and indoleamine 2,3-dioxygenase activity are increased by raising extracellular tryptophan concentrations. The pattern of intracellularly formed pteridines upon stimulation with {gamma}-interferon shows the unique characteristics of human monocytes/macrophages. Neopterin, monapterin, and biopterin are produced in a 50:2:1 ratio. Thus, the THP-1 cell line provides a permanent, easily accessible in vitro system for studying the induction and mechanism of neopterin formation.

1 Supported by the Austrian Research Funds "Zur Förderung der wissenschaftlichen Forschung," Project 6922.

2 To whom requests for reprints should be addressed.

Received 9/11/89. Revised 1/11/90.


This article has been cited by other articles:


Home page
BloodHome page
D. E. Schiff, J. Rae, T. R. Martin, B. H. Davis, and J. T. Curnutte
Increased Phagocyte Fcgamma RI Expression and Improved Fcgamma -Receptor-Mediated Phagocytosis After In Vivo Recombinant Human Interferon-gamma Treatment of Normal Human Subjects
Blood, October 15, 1997; 90(8): 3187 - 3194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Deshpande, J.-M. Goust, A. K. Chakrabarti, E. Barbosa, E. L. Hogan, and N. L. Banik
Calpain Expression in Lymphoid Cells
J. Biol. Chem., February 10, 1995; 270(6): 2497 - 2505.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.